IKOS CIF’s Merck MRK Stock Holding History

IKOS CIF’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-10,027	Closed	-$569K	–	294
2014 Q3	$569K	Buy	+10,027	New	+$563K	0.82%	27
2013 Q3	–	Sell	-10,284	Closed	-$459K	–	237
2013 Q2	$459K	Buy	+10,284	New	+$459K	0.85%	37

Other funds holding MRK

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

IKOS CIF's MRK Position: Q4 2014 in Review

IKOS CIF sold out of Merck (MRK) in Q4 2014, closing a stake of 10,027 shares — an estimated $569K sold.

IKOS CIF first reported a position in MRK in Q2 2013 and held it in 2 quarters. The position peaked at $569K in Q3 2014. 1,722 funds tracked by Wall St. Rank hold MRK as of Q4 2014.

IKOS CIF reported no remaining Merck position as of Q4 2014 after selling out during the quarter.
IKOS CIF sold 10,027 Merck shares in Q4 2014, an estimated $569K.
IKOS CIF first reported a position in Merck in Q2 2013 and held it in 2 quarters.
IKOS CIF's Merck position peaked at $569K in Q3 2014.
1,722 funds tracked by Wall St. Rank held Merck as of Q4 2014.

Based on IKOS CIF's 13F filing for Q4 2014, filed 11 Feb 2015.